How many places are getting protection from the pandemic virus?

Do you wonder what other countries are doing to protect their citizens from COVID-19? I have. I knew that a couple of other vaccines were being distributed, but I had no idea 13 were approved and used.

Vaccines Summary

https://www.medicalnewstoday.com/articles/global-covid-19-vaccine-summary-side-effects\. This link provides an excellent overall summary of the who, what, where, etc.

Pfizer (BNT162b2)

https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=RP. Pfizer is one of the vaccines we hear and read about often. It is an mRNA type of vaccine with around 95% efficacy. It is used in the United States, Canada, 26 countries in Europe, six countries in the Middle East, Chile, Costa Rica, and Singapore.

Moderna (mRNA-1273)

https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy Moderna’s vaccine also uses the mRNA type of vaccine with approximately the same effectiveness. This vaccine is distributed outside the United States in 35 countries in Europe, two in the Middle East, Singapore, and Canada.

Johnson & Johnson (Ad26.COV2.S)

https://www.jnj.com/johnson-and-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial. J&J’s vaccine is a viral vector type that protects two out of every three people. It is distributed in the United States, United Kingdom, Canada, the European Union, the African Union, Columbia, Chile, New Zealand, and South Korea.

AstraZeneca (AZD1222)

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext. This vaccine is also a viral vector that protects slightly over four people out of every five. It is difficult to determine where this vaccine is being used since over a dozen stopped its usage within the past two weeks. The literature says dozens of countries plus India.

Serum Institute of India (Covishield)

https://www.bbc.com/news/world-asia-india-55748124. The name of the vaccine is different, but the vaccine is the same viral vector, the AstraZeneca vaccine. India is the first to receive the vaccine. Distribution started recently in Ghana with promises to many other African nations. Doses will be sent to the United States upon the approval of the AstraZeneca vaccine there.

CanSino (Ad5-nCov)

https://www.bloomberg.com/news/articles/2021-03-25/china-s-cansino-says-european-vaccine-order-talks-are-underway. China’s viral vector vaccine has similar properties to J&J’s vaccine – two out of three people are protected. China is in talks to supply their vaccine to Europe. This vaccine is approved in China, Mexico, and Pakistan.

Gamaleya (Sputnik V)

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext. The Russian viral vector vaccine has over 90% efficacy. Outside the Soviet Union, three countries in Europe, three countries in South America, two countries in northern Africa, Iran, India, and China.

Bharat Biotech (Covaxin)

https://www.bharatbiotech.com/images/press/covaxin-phase3-efficacy-results.pdf. This Indian vaccine uses an inactivated SARS-CoV-2 virus and offers protection around 80%. The only country using this vaccine outside India is Zimbabwe.

Sinopharm (BBIBP-CorV)

https://www.nature.com/articles/s41541-021-00292-w. This vaccine is from China and offers around 80% effectiveness. Distribution of this inactivated vaccine has been to China, Turkey, Brazil, Chile, Bahrain, and the UAE.

Sinopharm (Inactivated Vero Cell)

https://www.bioworld.com/articles/504243-two-covid-19-vaccines-approved-in-china-in-less-than-24-hours. China offers another inactivated vaccine that offers protection for nearly three out of four people. It is being administered domestically and to five countries in the Middle East.

Sinovac (CoronaVac)

https://www.reuters.com/article/healthcoronavirus-brazil-coronavirus/chinas-sinovac-vaccine-has-general-efficacy-of-50-4-in-brazil-trials-says-butantan-idUSE5N2HA01G. This inactivated COVID-19 vaccine from China shows only a 50% effectiveness rating. It is being distributed to Turkey, the Philippines, Indonesia, Jordan, Ukraine, Algeria, and Brazil.

Anjui Zhifei Longcom (ZF2001)

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00127-4/fulltext. This Chinese coronavirus vaccine uses a protein subunit to offer protection. A dimeric form of COVID-19, the MERS-CoV RBD is thought to provide high levels of protection from the SARS-CoV-2 virus. Only a tiny portion of the virus, a subunit, is used to offer the protective response. It appears to provide comparable protection to the other coronavirus vaccines in the 70% efficacy range. This vaccine is used in China, Ecuador, Malaysia, Pakistan, and Uzbekistan.
FBRI (EpiVacCorona)

https://covid19.trackvaccines.org/vaccines/32/. This Russian protein subunit vaccine is being used in Russia and Turkmenistan. This vaccine offers slightly over 50% effectiveness.

Conclusion

https://covid19.trackvaccines.org/vaccines/. This link will provide information on 13 of over 100 vaccines currently in COVID-19 clinical trials. Every month, more vaccines are being approved and distributed worldwide.

Live Longer & Enjoy Life! – Red O’Laughlin – RedOLaughlin.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *